19.01.2015 Views

2294 part 1 final report.pdf - Agra CEAS Consulting

2294 part 1 final report.pdf - Agra CEAS Consulting

2294 part 1 final report.pdf - Agra CEAS Consulting

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Prevention and control of animal diseases worldwide<br />

Part I: Economic analysis: prevention versus outbreak costs<br />

In the case of HPAI, similar factors enter into play in the fight against the disease. In <strong>part</strong>icular, the<br />

nature of the disease (for example, now acknowledged endemic in many <strong>part</strong>s of SE Asia), the state of<br />

VS preparedness in each country, and the existing farming structures (e.g. geographically highly<br />

dispersed poultry population) affect the needs and costs of establishing effective surveillance,<br />

biosecurity and improving prevention and control in each country.<br />

---------------------------------<br />

Our analysis in this section leads us to the following conclusions:<br />

Literature review: comparison of prevention to outbreak costs<br />

From the reviewed literature, in relatively few cases the analysis on the benefits of improved<br />

animal disease prevention and control can be defined as a full classical CBA. The majority<br />

of the reviewed studies consider the most measurable types of benefit, notably trade impacts.<br />

They also tend to focus on specific components of prevention and control systems, specific<br />

diseases, countries (or even regions within countries), specific epidemiological conditions in<br />

which prevention and control measures may be applied, specific types of benefit and specific<br />

scenarios and assumptions under which the benefits may be derived.<br />

In all the cases reviewed here (Table 10), such studies conclude that the significant benefits<br />

that accrue from improved prevention and control measures outweigh the cost of<br />

investment. For example:<br />

• In Latin America, an investment on improvements to animal health of some additional<br />

US$ 157 million per year over 15 years generates a Net Present Value of US$ 1.9 billion.<br />

In Africa, an investment of Euro 14.7 to control CBPP could save Euro 30 million in<br />

losses from morbidity/mortality, leading to a net benefit of Euro 15.4 million.<br />

• In Asia (Philippines, Thailand), eradication programmes for FMD have been assessed to<br />

provide benefits in terms of improved trade and market access that are several times<br />

worth the investment (the extent of the benefit depending on the underlying<br />

assumptions).<br />

Results of this type of analysis depend heavily on the underlying scenarios/assumptions, and<br />

the implication of this is that a) they need to be interpreted within the context in which they<br />

have been generated; and b) comparison and extrapolations from individual case studies are<br />

constrained and should be treated with caution.<br />

Civic <strong>Consulting</strong> • <strong>Agra</strong> <strong>CEAS</strong> <strong>Consulting</strong> 94

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!